Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
ALL MEDICAL CODES IN CATEGORY Administration of Drugs

2025 HCPCS code M0240

Administration of casirivimab and imdevimab via IV infusion or subcutaneous injection, including post-administration monitoring; subsequent repeat dose.

2025 HCPCS code M0240

Dùng casirivimab và imdevimab qua truyền tĩnh mạch hoặc tiêm dưới da, bao gồm theo <a href="../medical-coding/reference/IV" target="_blank" title="Medical Code IV 2025">dõi</a> sau khi dùng thuốc; liều lặp lại sau đó.

2025 HCPCS code M0240

Administration de casirivimab et d'imdevimab par perfusion <a href="../medical-coding/reference/IV" target="_blank" title="Medical Code IV 2025">IV</a> ou injection sous-cutanée, y compris surveillance après administration ; administration répétée ensuite.

2025 HCPCS code M0240

通过<a href="../medical-coding/reference/IV" target="_blank" title="Medical Code IV 2025">静脉</a>输液或皮下注射给药卡西里维单抗和依德维单抗，包括给药后监测；随后的重复剂量。

2025 HCPCS code M0240

Administración de casirivimab e imdevimab mediante perfusión <a href="../medical-coding/reference/IV" target="_blank" title="Medical Code IV 2025">intravenosa</a> o inyección subcutánea, incluida la monitorización posterior a la administración; repetición posterior de la dosis.

2025 HCPCS code M0240

Введение казиривимаба и имдевимаба путем <a href="../medical-coding/reference/IV" target="_blank" title="Medical Code IV 2025">внутривенной</a> или подкожной инъекции, включая мониторинг после введения; последующая повторная доза.

2025 HCPCS code M0240

إعطاء كاسيريفيماب وإيمديفيماب عن طريق الحقن <a href="../medical-coding/reference/IV" target="_blank" title="Medical Code IV 2025">الوريدي</a> أو الحقن تحت الجلد، بما في ذلك مراقبة ما بعد الإدارة؛ تكرار الجرعة اللاحقة.

2025 HCPCS code M0240

Verabreichung von Casirivimab und Imdevimab als <a href="../medical-coding/reference/IV" target="_blank" title="Medical Code IV 2025">intravenöse</a> Infusion oder subkutane Injektion, einschließlich Überwachung nach der Verabreichung; anschließende Wiederholungsdosis.

2025 HCPCS code M0240

<a href="../medical-coding/reference/IV" target="_blank" title="Medical Code IV 2025">IV</a> 주입 또는 피하 주사를 통한 카시리비맙과 임데비맙의 투여 (투여 후 모니터링 포함), 후속 반복 투여

2025 HCPCS code M0240

Pangangasiwa ng casirivimab at imdevimab sa pamamagitan ng <a href="../medical-coding/reference/IV" target="_blank" title="Medical Code IV 2025">IV</a> fusion o subkutanong iniksyon, kabilang ang pagsubaybay sa pagkatapos ng pangangasiwa; kasunod na ulit na dosis.